Metformin-associated lactic acidosis in a patient with normal kidney function

Diabetes Research and Clinical Practice

Volumn 96, Issue 3, 2012, Pages

  van Sloten, T T ^a   Pijpers, E ^a   Stehouwer, C D A ^a   Brouwers, M C G J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Biguanides; Metformin; Treatment type 2 diabetes

Indexed keywords

LACTIC ACID; METFORMIN;

AGED; ARTICLE; CASE REPORT; DELIRIUM; DRUG RECHALLENGE; DRUG WITHDRAWAL; GENETIC SUSCEPTIBILITY; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PROSTATITIS;

ACIDOSIS, LACTIC; AGED, 80 AND OVER; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; METFORMIN; RISK FACTORS;

EID: 84862181103     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.07.021     Document Type: Article

References (5)

1. Edwards I.R., Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000, 356:1255-1259.
2. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010, 4:CD002967.
3. Shu Y., Sheardown S.A., Brown C., Owen R.P., Zhang S., Castro R.A., et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 2007, 117:1422-1431.
4. Boyle J.G., Salt I.P., McKay G.A. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet Med 2010, 27:1097-1106.
5. Wang D.S., Kusuhara H., Kato Y., Jonker J.W., Schinkel A.H., Sugiyama Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003, 63:844-848.